Added to YB: 2023-10-15
Pitch date: 2023-10-15
VNDA [bullish]
Vanda Pharmaceuticals Inc.
+40.88%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
Market Cap
$366.5M
Pitch Price
$4.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.82
P/E
-1.66
EV/Sales
0.53
Sector
Biotechnology
Category
N/A
Show full summary:
Vanda Pharmaceuticals Inc. VNDA
A summary for this pitch has not been created yet.
Read full article (0 min)